- Cell and molecular biology
- Epidemiology, prevention and public health
- Experimental therapeutics and drug development
- Genetics, genomics and epigenetics
- Infection, immunity and cancer vaccines
- Medical and radiation oncology
- Surgical oncology, cancer imaging and interventional therapeutics
- Systems biology, post-genomic analysis and emerging technologies
The Editors of BMC Cancer and BMC Microbiology are exited to announce the launch and invite of submissions to our ‘Microbiome and Cancer’ cross journal collection. Guest edited by Prof. Christopher Staley and Dr. Sean Devlin.
Open for submissions until 1st May 2021. Submit now!
Support and Guidance
Featured video: Microparticles, breast cancer's secret weapon?
How do physicians and nurses perceive the benefits of clinical trial participation compared with standard care? Is it justified to claim that clinical trial participation improves outcomes for cancer patients? Zandra Nielsen et al. present their latest findings of a mixed-methods study in Scandinavia.
Aims and scope
Click here to view which Articles have been shared most in the last 6 months!
BMC Series Focus Issue
In support of World Diabetes Day on 14th November, this BMC Series focus issue places the spotlight on research advancing knowledge and patient care in diabetes. Our open-access content is available permanently, and highlights include genomics, neuroscience, and public health topics.
Follow Nobel Prize laureates James P. Allison's and Tasuku Honjo's footsteps and experience the genesis of a new field of cancer therapy. BMC Cancer Editorial Board Member Dr. Sheng Guo from Pittsburgh University takes us on an exciting journey of discovery...
BMC Series Blog
18 November 2020
16 November 2020
2019 Journal Metrics
3.15 - 2-year Impact Factor
3.432 - 5-year Impact Factor
1.021 - Source Normalized Impact per Paper (SNIP)
1.186 - SCImago Journal Rank (SJR)
Social Media Impact